These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 4027505

  • 21. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study.
    Strauss AL, Coe FL, Deutsch L, Parks JH.
    Am J Med; 1982 Jan; 72(1):17-24. PubMed ID: 7058820
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Diagnosis and prevention of uric acid stones].
    Ferrari P, Bonny O.
    Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118
    [Abstract] [Full Text] [Related]

  • 27. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY, Sakhaee K, Fuller CJ.
    Trans Assoc Am Physicians; 1983 Sep; 96():294-305. PubMed ID: 6679957
    [Abstract] [Full Text] [Related]

  • 28. Hyperuricosuric calcium oxalate nephrolithiasis.
    Coe FL.
    Kidney Int; 1978 May; 13(5):418-26. PubMed ID: 661071
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
    Arowojolu O, Goldfarb DS.
    J Nephrol; 2014 Dec; 27(6):601-5. PubMed ID: 24687403
    [Abstract] [Full Text] [Related]

  • 33. [A study of allopurinol in the prevention of recurrent calcium oxalate stones].
    Sonoda T, Koide T, Oka T, Sakaguchi H, Itatani H, Ohkawa T, Ebisuno S, Morimoto S, Yoshida O, Okada Y.
    Hinyokika Kiyo; 1985 Nov; 31(11):2071-9. PubMed ID: 4091144
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of Selective Versus Empiric Pharmacologic Preventative Therapy With Kidney Stone Recurrence.
    Hsi RS, Yan PL, Goldfarb DS, Egbuji A, Si Y, Shahinian V, Hollingsworth JM.
    Urology; 2021 Mar; 149():81-88. PubMed ID: 33352163
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. High urinary excretion of uric acid combined with high excretion of calcium links kidney stone disease to familial hypertension.
    Tisler A, Pierratos A, Honey JD, Bull SB, Rosivall L, Logan AG.
    Nephrol Dial Transplant; 2002 Feb; 17(2):253-9. PubMed ID: 11812875
    [Abstract] [Full Text] [Related]

  • 39. [Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].
    Dumoulin G, Haton D, Wolf JP, Henriet MT, Nguyen NU, Mougin C, Saint-Hillier Y, Combes M, Berthelay S.
    Nephrologie; 1984 Feb; 5(5):189-91. PubMed ID: 6531054
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.